Director Global Oncology Market Access - SacTMT
- Location
- Rahway, NJ
- Employment
- Full Time
- Work model
- On-Site
- Level
- Staff
- Salary
- $190.8k – $300.3k/yr
- Posted
Skills
About this role
Job Description
The Director, Oncology Global Market Access will lead global market access strategy for one more indications of our Company’s antibody drug conjugate program, Sac-TMT, working across development and commercialization to optimize patient access and long-term value. This role supports a high-priority oncology program with significant potential to improve outcomes for patients globally. The Director will be responsible for developing clear, actionable market access and pricing strategies that integrate payer needs, clinical development, evidence generation, commercial strategy, and evolving policy and competitive dynamics. A critical responsibility of the role is translating complex market access issues into concise, decision-ready recommendations. The successful candidate will bring business judgment, analytical capability, and the ability to influence decisions across a highly matrixed global organization. The Director will collaborate closely with Global and U.S. Market Access, Commercial, Clinical Development, Value & Implementation, Regulatory, Medical Affairs, Pricing, Forecasting, regional and local market access teams, and other cross-functional partners.
Primary Responsibilities
Lead global market access strategy for assigned indications, from clinical development through launch planning and commercialization. Develop clear, decision-ready recommendations that connect market access, pricing, evidence, clinical development, and commercial implications. Provide strategic market access input into clinical development and evidence-generation decisions, including patient population, endpoints, comparators, treatment setting, sequencing, evidence gaps, and other factors that may influence future payer value assessment and access. Lead continued development and evolution of the Global Plan for Access, ensuring that key access risks, opportunities, evidence requirements, and market archetype considerations are incorporated into asset strategy. Identify core value drivers and challenges to support value recognition and inform asset-level pricing strategy, informed by clinical evidence, unmet need, market readiness and competitive dynamics in define therapeutic areas. Lead global market access input to launch readiness and indication-expansion planning, identifying potential access barriers early and developing strategies to address them. Partner with U.S., regional, and local market access organizations to incorporate critical market realities into global strategy while maintaining an enterprise and global perspective. Assess payer trends, health technology assessment requirements, competitor developments, policy changes, pricing dynamics, and other external developments that could affect access or asset value. Translate complex analyses and perspectives from multiple markets and functions into clear strategic choices and strong recommendations. Represent Global Market Access in cross-functional teams and governance discussions, ensuring that access and pricing considerations are incorporated into key development and commercialization decisions. Partner effectively across Commercial, Clinical Development, CORE, Value & Implementation, Pricing, Forecasting, Medical Affairs, Regulatory, and regional/local Market Access teams to drive integrated asset strategy. Lead or coordinate market access analyses required to support key strategic decisions, including payer research, access scenario planning, forecast assumptions, launch sequencing, and risk/opportunity assessments. Communicate recommendations effectively to senior leaders and governance forums through concise presentations and compelling, evidence-based storytelling.
Qualifications
Required BA/BS in Business, Science, Health Economics, Public Health, or a related discipline. Minimum of 5 years of relevant experience in market access, pricing and reimbursement, biopharma-related management consulting, health economics/outcomes research, commercial strategy,